Author response: Prospective validation of the PML risk biomarker l-selectin and influence of natalizumab extended intervals
| Image |  |
|---|---|
| Description | scientific article published on 01 September 2020 |
| Author/s |
author: Tilman Schneider-Hohendorf Heinz Wiendl Nicholas Schwab |
| Publication date | September 1, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |